Mounjaro (tirzepatide) isnt FDA approved for weight loss yet, but is anticipated to be approved by end of 2023
Key Takeaways GLP-1 medications aren't causing gestational diabetes they may have been masking underlying metabolic dysfunction that becomes visible when the medication is stopped Thyroid problems can be "unmasked" by GLP-1 treatment because the medications signal to your brain that you're not starving, allowing the pituitary TSH to rise, sometime uncovering a pre-existing thyroid issue Zepbound may improve iron absorption if iron levels go too high, testing for hemochromatosis may be warranted To reduce injection site reactions: warm the medication to room temperature, clean and prep skin but don't over-rub with alcohol, inject at exactly 90 degrees, don't pinch the skin, and stay relaxed Diets cause fat regain at the cellular level it's chemistry, not willpower and the fat often accumulates in the visceral area around organs There's no need to increase your GLP-1 dose if you're making good progress an annual weight loss rate of 15% or higher is considered strong Notable Quote "You can't think that just because somebody's weight is high, it's because something they're doing is wrong
Dyersburg, Tennessee
For temporary relief only
Ready to Begin Your Tirzepatide Journey
If you have symptoms of PAD, such as leg pain or numbness, schedule a consultation today and take control of your vascular health
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
